Biotechnology & Therapeutic Innovation Expertise
At Ausovi, we pioneer novel analog compounds through rigorous in-house discovery and strategic academic partnerships. From initial target identification to preclinical proof-of-concept, we engineer molecules with optimized specificity, stability, and therapeutic potential – building a growing portfolio of life-changing therapeutics that address critical unmet medical needs.
Our process begins with In-House Discovery & Design – the essential first step where we leverage advanced computational modeling, structure-based engineering, and proprietary insights to create high-potential analog candidates. This foundational phase ensures every subsequent effort is focused, scientifically sound, and positioned for strong intellectual property protection and long-term value creation.
Discovery & Design Challenge
Many early-stage therapeutic programs fail due to poorly defined targets, suboptimal molecular starting points, or insufficient early IP protection – wasting time and resources before preclinical work even begins.
At Ausovi, we treat In-House Discovery & Design as the single most critical investment. By starting with deep computational analysis, structure-guided iteration, and early patent strategy, we dramatically de-risk downstream development and maximize the probability of creating differentiated, protectable assets with real therapeutic impact.
labstica list
- Advanced computational modeling for rapid analog engineering
- Structure-based design targeting enhanced specificity & stability
- Early provisional filings to secure composition-of-matter protection
- Proprietary data generation from day one
- Seamless integration with academic expertise for validation
- Clear prioritization of high-potential candidates for advancement
AI Discovery
AI-assisted modeling and virtual screening to identify optimized analog structures.
Precision Synthesis
Scalable chemical routes producing high-purity candidates for preclinical testing.
Preclinical Validation
In vitro/in vivo models assessing efficacy, safety, and pharmacokinetics.
IP Strategy
Layered patent protection and strategic asset development for long-term value.